NASDAQ · ISRG
Intuitive Surgical, Inc.
$448.76+$4.58 (+1.03%)
Intuitive Surgical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 25.69% below the high.
Loading market information…
JPX · 7733.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:42 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Olympus Corporation’s quoted price sits in the lower half of its reported 52-week range, 21.01% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Olympus Corporation’s forward annual dividend is ¥60 per share, paid semi-annual. The forward yield is 3.44% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Olympus Corporation’s next earnings report is currently expected on Nov 10, 2026, with estimated earnings per share of ¥22. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Olympus Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Olympus Corporation, a global enterprise headquartered in Tokyo, Japan, manufactures and distributes high-precision machinery and instrumentation worldwide. The company, originally established in 1919 as Olympus Optical Co., Ltd., adopted its current name in October 2003. Its extensive operations are structured into four primary divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and a segment designated as "Others." The Endoscopic Solutions division specializes in developing and providing gastrointestinal and surgical endoscopes, comprehensive endoscopy systems, and associated repair services. The Therapeutic Solutions segment focuses on products for urology, gynecology, and ear, nose, and throat (ENT) procedures, alongside endo-therapy devices, energy-based surgical tools, and disposable surgical instruments. Within Scientific Solutions, Olympus supplies biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing (NDT) equipment, and X-ray fluorescence (XRF) analyzers. The "Others" segment encompasses biomedical materials and orthopedic equipment. Beyond these core areas, the company also offers a broader array of medical devices, including surgical microscopes, endoscope reprocessing units, electrosurgical tools, and respiratory-endotherapy devices, complemented by system integration and ongoing maintenance services.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:57 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2025 | May 13, 2025 | ¥37+55.11% vs estimate | ¥272.11B+0.67% vs estimate |
|---|
| Q3 2025 | Feb 14, 2025 | ¥24-29.19% vs estimate | ¥251.19B+0.52% vs estimate |
|---|
| Q2 2025 | Nov 8, 2024 | ¥30-0.8% vs estimate | ¥239.21B-1.08% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$448.76+$4.58 (+1.03%)
Intuitive Surgical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 25.69% below the high.
$97.11+$2.33 (+2.46%)
Medtronic Plc’s quoted price sits in the upper half of its reported 52-week range, 8.67% below the high.
$311.36+$7.36 (+2.42%)
Stryker Corporation’s quoted price sits in the lower half of its reported 52-week range, 20.03% below the high.
$198.34+$3.18 (+1.63%)
Becton, Dickinson and Company’s quoted price sits in the upper half of its reported 52-week range, 1.06% below the high.
€42.89+€0.30 (+0.7%)
Siemens Healthineers AG’s quoted price sits in the upper half of its reported 52-week range, 13.7% below the high.
$76.42+$0.60 (+0.79%)
GE HealthCare Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.87% below the high.
CN¥179.20+CN¥0.20 (+0.11%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 20.18% below the high.
¥2,393+¥24 (+1.01%)
Terumo Corporation’s quoted price sits in the upper half of its reported 52-week range, 11.01% below the high.
